Altimmune, Inc. (ALT) Total liabilities 2016–2025
Altimmune, Inc. (ALT) total liabilities at each fiscal year-end, per SEC filings.
$55.0MFY2025 · since FY2016: $6.2M → $55.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $55.0M | +248.4% |
| FY2024 | $15.8M | -4.5% |
| FY2023 | $16.5M | -23.5% |
| FY2022 | $21.6M | +9.7% |
| FY2021 | $19.7M | +2.6% |
| FY2020 | $19.2M | +125.3% |
| FY2019 | $8.5M | +32.6% |
| FY2018 | $6.4M | -55.1% |
| FY2017 | $14.4M | +131.8% |
| FY2016 | $6.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice